期刊
JOURNAL OF MATERIALS CHEMISTRY B
卷 2, 期 24, 页码 3759-3770出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c4tb00390j
关键词
-
Chitosan-reduced graphene oxide (rGO) nanocomposites were synthesized through a biocompatible reduction process and were first reported for applications in transdermal drug delivery devices, such as microneedle arrays. Introducing rGO improved the mechanical properties of chitosan, with the strongest nanocomposites containing 1 wt% and 2 wt% rGO chosen to undergo drug delivery testing. The addition of rGO increased the electrical conductivity of chitosan, allowing the nanocomposites to be used for electroporation or iontophoresis drug delivery applications. The rGO content was proven to be an important factor for drug delivery due to the bonding of drug onto rGO. Increasing the rGO content allowed for a quicker and more substantial drug release, allowing for a controlled drug release rate. The nanocomposites also exhibited pH dependent release behaviour, with a reduced release rate in the presence of an acidic medium. The biodegradation rate of chitosan decreased when rGO was added but the biodegradation rates of the nanocomposites are not dependent on the rGO concentration, with nanocomposites of 1 wt% and 2 wt% rGO possessing a similar biodegradation path. The use of the nanocomposite in a microneedle array was shown through compression testing and drug release testing in a pseudo-in vivo environment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据